Capital International Investors
CLBT icon

Capital International Investors’s Cellebrite CLBT Stock Holding History

Capital International Investors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1M Sell
2,060,957
-217,083
-10% -$2.87M 0.01% 384
2026
Q1 		$31.4M Hold
2,278,040
– – 0.01% 364
2025
Q4 		$41.1M Buy
+2,278,040
New +$40.9M 0.01% 368

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Capital International Investors's CLBT Position: Q2 2026 in Review

Capital International Investors reduced its Cellebrite (CLBT) stake by 9.5% in Q2 2026, selling an estimated $2.87M and leaving 2,060,957 shares worth $30.1M. The position accounts for 0.01% of the portfolio, ranked #384.

Capital International Investors first reported a position in CLBT in Q4 2025 and has held it in 3 quarters since. The position peaked at $41.1M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Capital International Investors held 2,060,957 shares of Cellebrite worth $30.1M as of Q2 2026.
  • Capital International Investors sold 217,083 Cellebrite shares in Q2 2026, an estimated $2.87M.
  • Cellebrite made up 0.01% of Capital International Investors's portfolio in Q2 2026, its #384 holding.
  • Capital International Investors first reported a position in Cellebrite in Q4 2025 and has held it in 3 quarters since.
  • Capital International Investors's Cellebrite position peaked at $41.1M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.